These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32503225)

  • 1. Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling.
    To NB; Nguyen YT; Moon JY; Ediriweera MK; Cho SK
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32503225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
    Prajapati KS; Kumar S
    J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
    Liu LC; Wu YC; Kuo SC; Ho CT; Way TD; Chen ST
    Anticancer Res; 2018 May; 38(5):2849-2859. PubMed ID: 29715108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
    Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan.
    Alaaeldin R; Ali FEM; Bekhit AA; Zhao QL; Fathy M
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7/SC Breast Cancer Cells.
    To NB; Truong VN; Ediriweera MK; Cho SK
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
    Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
    Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyphenols Extracted from
    Ko YS; Jung EJ; Go SI; Jeong BK; Kim GS; Jung JM; Hong SC; Kim CW; Kim HJ; Lee WS
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32326231
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.
    Zhao Q; Liu Y; Wang T; Yang Y; Ni H; Liu H; Guo Q; Xi T; Zheng L
    Eur J Pharmacol; 2020 Oct; 884():173359. PubMed ID: 32738343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
    Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR
    J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
    Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
    Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
    Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
    Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.
    Sulaiman NB; Mohan CD; Basappa S; Pandey V; Rangappa S; Bharathkumar H; Kumar AP; Lobie PE; Rangappa KS
    Int J Oncol; 2016 Sep; 49(3):1221-9. PubMed ID: 27500741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Breast Cancer Activities of Ketoprofen-RGD Conjugate by Targeting Breast Cancer Stem-Like Cells and Parental Cells.
    Noori S; Rajabi S; Tavirani MR; Shokri B; Zarghi A
    Anticancer Agents Med Chem; 2021; 21(8):1027-1036. PubMed ID: 32900351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.